We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EB
801
DELISTED
Eventbrite
EB
$67K 0.01%
+11,073
New +$93.3K
RYAM icon
802
Rayonier Advanced Materials
RYAM
$562M
$65K 0.01%
20,525
-19,170
-48% -$76.7K
CASA
803
DELISTED
Casa Systems, Inc. Common Stock
CASA
$65K 0.01%
20,898
+5,690
+37% +$22.5K
PRTS icon
804
CarParts.com
PRTS
$42.6M
$61K 0.01%
1,178
-4,262
-78% -$310K
QNCX icon
805
Quince Therapeutics
QNCX
$21.5M
$61K 0.01%
230
-827
-78% -$315K
AMSC icon
806
American Superconductor
AMSC
$1.29B
$58K 0.01%
13,344
-10,358
-44% -$53.6K
TRUE
807
DELISTED
TrueCar
TRUE
$58K 0.01%
38,363
-28,137
-42% -$64.2K
RAIL icon
808
FreightCar America
RAIL
$263M
$57K 0.01%
15,389
-10,327
-40% -$43.1K
GSM icon
809
FerroAtlántica
GSM
$590M
$56K 0.01%
+10,558
New +$65.4K
MTA
810
Metalla Royalty & Streaming
MTA
$689M
$52K 0.01%
+13,445
New +$58.5K
RXT icon
811
Rackspace Technology
RXT
$960M
$51K 0.01%
12,401
-91,281
-88% -$530K
TCRR
812
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$45K 0.01%
25,225
-57,529
-70% -$167K
STIM icon
813
Neuronetics
STIM
$127M
$38K 0.01%
+12,018
New +$43.7K
PRAX icon
814
Praxis Precision Medicines
PRAX
$8.11B
$37K 0.01%
+1,080
New +$53.8K
TELL
815
DELISTED
Tellurian Inc.
TELL
$33K 0.01%
+13,878
New +$50.1K
SUNL
816
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$28K ﹤0.01%
1,112
-578
-34% -$37.1K
AAOI icon
817
Applied Optoelectronics
AAOI
$6.14B
-39,797
Closed -$62K
AAPL icon
818
Apple
AAPL
$4.97T
-9,980
Closed -$1.36M
ACHC icon
819
Acadia Healthcare
ACHC
$2.52B
-10,738
Closed -$726K
ACLS icon
820
Axcelis
ACLS
$3.44B
-4,780
Closed -$262K
AGCO icon
821
AGCO
AGCO
$8.41B
-3,300
Closed -$326K
AIR icon
822
AAR Corp
AIR
$5.4B
-31,299
Closed -$1.31M
AIRS icon
823
AirSculpt Technologies
AIRS
$308M
-17,082
Closed -$101K
AKA icon
824
a.k.a. Brands
AKA
$119M
-2,249
Closed -$74K
ALGM icon
825
Allegro MicroSystems
ALGM
$7.86B
-57,980
Closed -$1.2M

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.